No link to cardiac valvulopathy was seen in cabergoline treated patients
<p><strong>Objective:</strong> To evaluate the association between use of cabergoline in patients with prolactinoma and risk of developing clinically relevant cardiac valvular disease.</p> <p><strong>Method:</strong> This was a descriptive cross sectional st...
المؤلفون الرئيسيون: | K Dharshini, Noel Somasundaram, HMDPK Senevirathna, S Raj Kumar |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
Sri Lanka College of Endocrinologists
2012-10-01
|
سلاسل: | Sri Lanka Journal of Diabetes Endocrinology and Metabolism |
الموضوعات: | |
الوصول للمادة أونلاين: | https://sjdem.sljol.info/articles/4775 |
مواد مشابهة
-
Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
حسب: Shruti Khare, وآخرون
منشور في: (2017-01-01) -
Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma
حسب: Annabelle G Hayes, وآخرون
منشور في: (2023-01-01) -
Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
حسب: Youngki Lee, وآخرون
منشور في: (2014-09-01) -
Spontaneous reduction of prolactinoma post cabergoline withdrawal
حسب: Sampath Kumar Venkatesh, وآخرون
منشور في: (2012-01-01) -
The course of pregnancy and delivery in patients with prolactinoma during treatment with cabergoline
حسب: Larisa Dzeranova, وآخرون
منشور في: (2016-11-01)